Alkem Laboratories Share Price in Focus; German Health Authority Issues EU GMP Certificate for Baddi Plant

Written by: Team Angel OneUpdated on: 16 Mar 2026, 4:34 pm IST
Alkem Laboratories announced that its Baddi plant has received an EU GMP certificate from the German health authority.
Alkem Laboratories Share Price
ShareShare on 1Share on 2Share on 3Share on 4Share on 5

Alkem Laboratories Ltd has informed the stock exchanges that its manufacturing facility at Baddi, Himachal Pradesh, has received a European Union Good Manufacturing Practice (EU GMP) compliance certificate. The certificate was issued after an inspection conducted by the German health authority.  

The disclosure was made through a regulatory filing dated 14 March 2026.  

Inspection Conducted in November 2025 

The inspection was carried out by the Department of Pharmacy (Human Medicines), Germany between 4 November and 10 November 2025 at the company’s Baddi manufacturing unit.  

Following the inspection, the authority issued a “Certificate of GMP Compliance of a Manufacturer”, confirming that the facility complies with the manufacturing and quality standards required under EU regulatory guidelines.  

The certificate will remain valid for 3 years from the date of inspection, according to the company’s filing.  

Regulatory Filing  

The company said the disclosure was made under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which requires listed entities to inform exchanges about material developments.  

Alkem had earlier informed the exchanges on 10 November 2025 that the German health authority was carrying out an EU GMP inspection at the Baddi facility. The latest filing confirms the outcome of that inspection.  

Compliance with EU Manufacturing Standards 

EU GMP inspections assess whether pharmaceutical manufacturing facilities meet the standards required for producing medicines intended for the European Union market. The checks typically cover manufacturing practices, quality systems, documentation, and facility conditions. 

Companies exporting pharmaceutical products to the EU are required to maintain compliance with these standards and undergo inspections by authorised European regulators. 

Read MoreAlkem Laboratories Arm Intends to Acquire Up to 55% Stake in Occlutech Holding! 

Alkem Laboratories Share Price Performance  

As of March 16, 2026, 10:54 am, Alkem Laboratories Ltd share price was trading at ₹5,249.50, a 1.98% decrease from the previous closing price. 

Conclusion 

With the issuance of the certificate, Alkem Laboratories’ Baddi facility has been confirmed as compliant with EU Good Manufacturing Practice standards following the German authority’s inspection. The certification remains valid for 3 years from the inspection date, as stated in the company’s exchange filing. 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.   
 
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

Published on: Mar 16, 2026, 11:02 AM IST

Team Angel One

Team Angel One is a group of experienced financial writers that deliver insightful articles on the stock market, IPO, economy, personal finance, commodities and related categories.

Know More

We're Live on WhatsApp! Join our channel for market insights & updates

Open Free Demat Account!

Join our 3.5 Cr+ happy customers

+91
Enjoy Zero Brokerage on Equity Delivery
4.4 Cr+DOWNLOADS
Enjoy ₹0 Account Opening Charges

Get the link to download the App

Get it on Google PlayDownload on the App Store
Open Free Demat Account!
Join our 3.5 Cr+ happy customers